news

BGIN BLOCKCHAIN LIMITED Reports Unaudited Financial Results for the Full Year of 2025

SINGAPORE, April 25, 2026 (GLOBE NEWSWIRE) -- BGIN BLOCKCHAIN LIMITED (“BGIN” or the “Company”; NASDAQ: BGIN), a digital asset technology…

1 month ago

100 Free Spins Canada Casino 2026: Cazimbo Launches Free Spins No Deposit with Real Money Nationwide

VANCOUVER, CANADA, April 24, 2026 (GLOBE NEWSWIRE) --  100 free spins for real money online casino + no deposit offers…

1 month ago

Welnax Relief Chain Analyzed: All You Need To Know About Welnax Triple-Method Shoulder Massager

New York City, NY, April 24, 2026 (GLOBE NEWSWIRE) -- Welnax ReliefChain Shoulder Massager With no doubt, physical therapy is…

1 month ago

Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study

High Impact Session presented at Heart Rhythm Society's Congress in ChicagoFirst time showing results of new Less Invasive approachImprovement in…

1 month ago

Project Eleven Awards 1 BTC Q-Day Prize for Largest Quantum Attack on Elliptic Curve Cryptography to Date

Researcher breaks 15-bit ECC key on publicly accessible quantum hardware in a 512x jump from the previous public demonstration.NEW YORK,…

1 month ago

NYSE Content Update: AI Company Vast Data Announces $30 Billion Valuation

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, April 24, 2026 /PRNewswire/ -- The New York…

1 month ago

Reliance Digital’s ‘All About Apple’ Campaign Brings Best Apple Deals and Price Drops on iPhone 17, MacBook & More

MUMBAI, India, April 24, 2026 /PRNewswire/ -- Reliance Digital announces limited-period offers on the latest Apple products with significant price drops…

1 month ago

Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess

April 24, 2026 08:00 ET  | Source: Humacyte, Inc - Ex-U.S. rights realigned under amendment to distribution agreement with Fresenius…

1 month ago

Oncotelic Therapeutics Provides Corporate Update on Partnership Strategy

AGOURA HILLS, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”), a clinical-stage biopharmaceutical company…

1 month ago

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 24, 2026 08:00 ET  | Source: Aligos Therapeutics SOUTH SAN FRANCISCO, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Aligos…

1 month ago